「planner」の検索結果

Use when the user asks to "build the norm card for this platform", "what are the char limits and visible-fold cutoffs here", "is the LinkedIn link-in-first-comment thing documented or folklore", or "which of our platform cards are stale"; maintains the dated, versioned per-platform norm cards in the references/platforms/ pack — char limits, visible-fold cutoffs, hashtag norms, format/aspect specs, link and first-comment placement, disclosure-label mechanics, algorithm emphases (e.g. 小红书 search+saves weighting) — every row labeled platform-documented (official doc, Measured) or Estimated-folklore (named source) with last-verified and review-by dates, and any card past its review date flagged stale rather than trusted. Extends the single pack in place; never forks a second one. Not for picking which channels to run — use channel-portfolio-planner. 平台规范卡/字符限制/折叠线/话题标签/算法侧重/过期标记

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "allocate my influencer budget", "optimize spend across tiers", or "compare budget scenarios"; produces a tier/platform/content allocation table, ROI and CPM/CPE projections, scenario comparisons, and mid-campaign reallocation moves. Not for building the full campaign plan — use campaign-planner. 达人预算分配/投放预算优化

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "check if our surfaces have drifted from the canon", "watch for competitor repositioning", or "define when we should reposition"; produces a drift report — self-drift per flagship surface vs the narrative-registry canon over time (via wayback.py, change history Measured with as-of dates), competitor-repositioning alerts, an explicit repositioning-trigger condition set, and a D1/W1/M1 message-shift retro (intended vs actual pull-through, evidence-labeled) — feeding the TALE L drift-audit sub-items and the narrative-whiplash guardrail fact base. Not for the first-time consistency check before a surface ships — use narrative-cascade-planner; not for computing the TALE profile result or running the vetoes — use narrative-quality-auditor; not for echo-rate / AI-answer resonance measurement — use narrative-resonance-monitor. 自漂移监测/竞品重定位告警/重定位触发/叙事漂移复盘

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "plan how our narrative lands on every surface", "write per-surface message-match specs", or "brief each creative builder from the canon"; maps the narrative-registry canon onto every flagship surface (homepage, pricing, store listing, sales deck, social bio, docs, email) as a per-surface message-match spec — what claim, pillar, proof, and objection reframe each surface must carry — and cuts a handoff brief to each discipline's creative builder (content-writer, ad-creative-builder, email-creative-builder, social-creative-builder, message-house-builder), so the same story lands consistently everywhere. Not for writing the finished surface copy — use each discipline creative builder; not for the tier-scoped launch asset manifest — use launch-asset-packager; not for scoring cross-surface consistency — use narrative-quality-auditor; not for claim adjudication — use offer-claims-registry. 叙事落地/逐面消息一致/创意交接简报/画布传导

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "pick a launch date", "plan the launch window", or "set the embargo and lift time"; produces a candidate-window comparison table (conflict / tailwind / risk per window) built from industry-event cycles and the competitor launch calendar, a launch-week vs rolling-release format call, store-review buffer padding (labeled Estimated), and an embargo window definition (lift moment + timezone) submitted to the launch registry as a candidate. Not for judging the cultural moment itself — use trend-spotter; not for launch-day execution — use launch-day-conductor. 发布择时/发布窗口/竞品日历/禁运期窗口/审核缓冲

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "log this launch", query a launch date/embargo, record a stage transition, or update submissions/outcomes; curates launch facts through the append-only launches event stream with optimistic revisions and derived dossier/calendar views. Not for RAMP scoring — use launch-readiness-auditor; not for planning tier/window — use launch-tier-planner. 发布台账/发布日历/阶段与禁运期记录

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "pick a bid strategy", "set a tCPA/tROAS target", or "plan the learning-phase entry"; produces a bid-strategy choice (tCPA / tROAS / max-conversions / manual CPC), the starting target math, a portfolio grouping map, and a learning-phase entry plan. Not for splitting the budget across campaigns — use budget-optimizer; not for in-flight pacing/scale moves — use budget-pacing-monitor; not for scoring the account — use ad-account-auditor. 出价策略/tCPA目标/tROAS/学习期

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "monetize my newsletter", "build a sponsorship rate card", or "model paid-subscription revenue"; produces a revenue model (paid tiers, ad/sponsorship inventory + CPM/flat rate card, referral/boost loops), a list-growth ↔ revenue projection, and honest-offer / disclosure checks for the SEND-D lever. Not for scoring the whole program or running D1 — use email-quality-auditor; not for the return math — use roi-calculator; not for the post-click page — use landing-optimizer. 邮件newsletter变现/赞助刊例/付费订阅测算

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to register/query a social channel, record channel state, cadence, governance, voice adaptation, UGC permission, or advocacy facts; curates them through the append-only channels event stream and derived views. Not for ECHO scoring — use social-quality-auditor; not for channel selection — use channel-portfolio-planner. 渠道台账/账号档案/UGC授权记录

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "check pacing", "am I over/under-spending", "is this campaign on track to hit budget", or "why did spend spike/stall mid-flight"; returns a spend-vs-target-curve read, learning-phase status, an over/under-delivery call, and a reallocation trigger. Not for initial budget allocation — use budget-optimizer; not for choosing the bid strategy — use bid-strategy-planner; not for the RQS gate — use ad-account-auditor. 付费广告预算节奏监控/跑量过快过慢/在途配速

日本語の概要は準備中です。原文の説明を表示しています。

Trace a codexhost feature change across UI surfaces, Host routing, Harness capabilities, state ownership, persistence, and validation. Use for impact analysis, design planning, or implementation handoff.

日本語の概要は準備中です。原文の説明を表示しています。

Generate comprehensive test plans, manual test cases, regression test suites, and bug reports for QA engineers. Includes Figma MCP integration for design validation.

日本語の概要は準備中です。原文の説明を表示しています。

Google API integration for blog performance: PageSpeed Insights, CrUX Core Web Vitals with 25-week history, Search Console performance, URL Inspection, Indexing API, GA4 organic traffic, NLP entity analysis for E-E-A-T, YouTube video search for embedding, and Google Ads Keyword Planner. Progressive feature availability based on credential tier (API key, OAuth/service account, GA4, Ads). Shares config with claude-seo at ~/.config/claude-seo/google-api.json. Use when user says "google data", "page speed", "core web vitals", "search console", "indexation", "GA4", "keyword research", "nlp entities", "blog performance", "youtube search", "google api setup".

日本語の概要は準備中です。原文の説明を表示しています。

Designs a coordinated multi-channel campaign or product launch around one story — objective, message, channel sequencing, timeline, assets, and the checklist that gets it out the door. Use this to plan a launch or campaign, sequence a go-to-market push, pressure-test a campaign before committing budget, or turn a product change into a coordinated set of activity. For ongoing channel programs rather than a bounded push, use `marketing-planning`.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete comorbidity-oriented shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Use when a study links two clinically related diseases through shared DEGs, enrichment, PPI hub genes, machine-learning feature selection, public diagnostic validation, gene-regulatory networks, immune infiltration, and optional downstream follow-up. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, machine-learning biomarker selection, immune/regulatory interpretation, multi-layer validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete conventional single-gene oncology research designs from a user-provided cancer context, target gene, and validation direction. Use when a study centers on a fixed candidate gene and needs expression, prognosis, clinicopathologic association, functional interpretation, immune context, genomic or epigenetic context, optional drug-response hypotheses, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete cross-disease shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Always use this skill whenever a user wants to design, plan, or build a multi-dataset study linking two related diseases through shared DEGs, enrichment, PPI hub genes, public validation, regulatory-network analysis, immune infiltration, drug-gene interaction screening, and optional qRT-PCR or cell-line validation. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, regulatory-network interpretation, immune/drug follow-up, bioinformatics-plus-validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete FAERS pharmacovigilance study designs for one-drug whole-profile safety mapping using signal detection, subgroup analysis, onset/seriousness characterization, and conservative label-gap interpretation.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete dual-disease shared-transcriptome biomarker and hub-gene research designs from a user-provided disease pair and shared-biology direction. Always use this skill whenever a user wants to design, plan, or build a non-oncology two-disease transcriptome study centered on per-disease differential expression, shared-signal intersection or concordance, PPI-based hub-gene prioritization, diagnostic evaluation across both diseases, immune infiltration context, pathway interpretation, and optional orthogonal validation. Covers five study patterns (shared-DEG-first workflow, hub-gene-first shared-biomarker workflow, hybrid shared-biomarker compression workflow, immune-context shared-biomarker workflow, orthogonal validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...

日本語の概要は準備中です。原文の説明を表示しています。

Design evidence-discovery and validation workflows for drug repurposing studies by integrating disease mechanisms, drug-target logic, expression reversal, real-world evidence, and validation routes into a closed-loop study blueprint.

日本語の概要は準備中です。原文の説明を表示しています。

Designs QTL colocalization studies that connect eQTL, pQTL, sQTL, or related molecular QTL signals with GWAS loci. Always use this skill whenever a user wants to plan, scope, or structure a locus-level study asking whether a GWAS association and a molecular QTL association may reflect the same underlying causal signal. Covers locus definition, QTL/GWAS source architecture, ancestry and LD alignment, single-locus vs multi-locus strategy, candidate-gene prioritization, optional fine-mapping, linked MR/SMR follow-up, and functional annotation. Always output four workload configurations (Lite / Standard / Advanced / Publication+) with a recommended primary plan, stepwise workflow, method rationale, evidence hierarchy, figure plan, minimal executable version, and strictly verified literature guidance with no fabricated references. Never equate colocalization with causality proof, mediation proof, or automatic target validation. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets, repositories, consortia, or public resources.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete Mendelian Randomization + single-cell transcriptomics (scRNA-seq) research designs from a user-provided direction. Always use this skill whenever a user wants to design, plan, or build a study combining MR and single-cell data — even if phrased as "help me write a paper on X", "design a bioinformatics study for Y", or "I want to study Z using MR and scRNA". Covers five study patterns (mechanism gene-set, key-cell, candidate-gene reverse validation, exposure-disease-cell triangulation, translational biomarker) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete FAERS-style pharmacovigilance disproportionality research designs from a user-provided drug class, comparator strategy, adverse-event domain, and patient-group stratification. Always use this skill whenever a user wants to design, plan, or build a spontaneous-report safety signal study using FAERS or a similar pharmacovigilance database, especially when the article logic includes product selection, indication-group stratification, MedDRA-based adverse-event extraction, serious-case filtering, suspect-drug and concomitant-exclusion logic, reporting odds ratio analysis, comparator-drug benchmarking, cross-drug comparison, and cautious signal interpretation without causal overclaiming. Covers five study patterns (single-drug disproportionality workflow, multi-drug class comparison workflow, indication-stratified workflow, comparator-controlled signal screening workflow...

日本語の概要は準備中です。原文の説明を表示しています。

Designs studies for predicting treatment response or resistance in biomedical and clinical research. Always use this skill when the user needs a treatment-response or resistance prediction study blueprint rather than a prognostic biomarker protocol, diagnostic test design, causal treatment-effect estimation, or a completed manuscript. Focus on responder definition, treatment context, baseline comparability, feature integration strategy, model development logic, validation architecture, and interpretation boundaries. Do not invent response rates, cohort size, assay readiness, regimen uniformity, literature support, or validation access.

日本語の概要は準備中です。原文の説明を表示しています。